Visit NavNeuro at:

Episode 63 | COVID-19: The Role of Neuropsychology – With Dr. Chaya Fridman


Emerging research suggests that a sizeable portion of individuals hospitalized due to COVID-19 develop cognitive and psychological sequelae. In our conversation with Dr. Chaya Fridman, a board-certified neuropsychologist at Cornell, we discuss the ways that SARS-CoV-2 (the virus that causes COVID-19) may lead to neurocognitive impairment, including both direct effects of the virus and secondary factors (e.g., respiratory distress and treatments used in the Intensive Care Unit). We review how the virus gains access to the central nervous system and the potential underlying mechanisms by which it causes an increased risk of stroke and other neurological issues. We also examine the long-term effects of prior coronaviruses (SARS-CoV and MERS-CoV) to attempt to forecast the long-term effects of COVID-19, with a focus on how neuropsychological practice (both inpatient and outpatient) might be affected.

apa-logo_white_screenThe International Neuropsychological Society is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Neuropsychological Society maintains responsibility for this program and its content.

Chaya Fridman
Instructor Credentials

Chaya B. (Gopin) Fridman, Ph.D., ABPP-CN, is Director of Neuropsychology at the Weill Cornell Specialty Center. She is a board certified subspecialist in pediatric neuropsychology and an Associated Professor at NYP/Weill-Cornell Medical College. Her clinical work and research interests include ADHD, affective disorders, movement disorders, epilepsy, and other conditions affecting cognition. She was the co-author of a recent TCN article entitled Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: implications for the current COVID-19 pandemic (see full reference below).

Topics Covered
  • Important terms and concepts related to COVID-19
  • Basic physiological and neurological mechanisms by which SARS-CoV-2 may cause psychiatric and neurological symptoms
  • Prevalence of neurological symptoms related to SARS-CoV-2 infection
  • Most common neurological symptoms resulting from SARS-CoV-2 infection
  • The relationship of SARS-CoV-2 infection to ischemic stroke and proposed mechanisms
  • How SARS-CoV-2 may enter the body through the olfactory system
  • Acute and long-term effects of SARS-CoV and MERS-CoV and how generalizable these findings are to SARS-CoV-2
  • Comorbidity of COVID-19 and post-traumatic stress disorder
  • How severity of COVID-19 illness is associated with cognitive and emotional symptoms
  • Previous SARS-CoV-2 infection and its potential relationship with later neurological or neurodegenerative conditions
  • Impact of COVID-19 infection on neurological and psychiatric symptoms in pediatric populations
  • Demographic moderators of severity of neurological, psychiatric, and behavioral symptoms in individuals with COVID-19 infection
  • The relationship of ICU admissions with negative cognitive functioning
  • Mechanical ventilation and its effect on cognitive functioning
  • Prevalence of delirium in individuals hospitalized and in long-term care facilities with COVID-19 infection
  • Long-term psychiatric health of ICU survivors
  • Inpatient neuropsychological evaluations of hospitalized individuals with COVID-19 infection
  • Teleneuropsychology procedures for neuropsychological evaluations of hospitalized individuals with COVID-19 infection and encountered challenges
  • Usefulness of behavioral observations and collateral report in understanding subtle cognitive and emotional manifestations in individuals with COVID-19 infection
  • Contribution of neuropsychologists to psychological care
  • Consideration of past history of COVID-19 infection in future neuropsychological evaluations
Educational Objectives
  • Describe basic biological mechanisms by which SARS-CoV-2 may lead to cognitive and psychiatric symptoms
  • List prevalence rates for neurological symptoms related to SARS-CoV-2
  • Discuss the relationship of SARS-CoV-2 to ischemic stroke, including proposed mechanisms underlying the association
  • Explain how research on SARS-CoV and MERS-CoV may be used to inform the understanding of SARS-CoV-2
  • Discuss ICU admission, mechanical ventilation, and their relationships to cognitive functioning
  • Describe the association between COVID-19 and delirium
  • Explain how neuropsychologists can contribute to clinical assessment and intervention in people with COVID-19
  • Apply knowledge of COVID-19 to clinical neuropsychological evaluations of patients
Target Audience
  • Introductory
  • Date Available: 2021-01-15
  • You may obtain CE for this podcast at any time.
Offered for CE
  • Yes
  • Members $20
  • Non-Members $25
Refund Policy
  • This podcast is not eligible for refunds
CE Credits
  • 1.0 Credit(s)
  • N/A
  • N/A
  • Abboud, H., Abboud, F. Z., Kharbouch, H., Arkha, Y., El Abbadi, N., & El Ouahabi, A. (2020). COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurgery.
  • Abdel-Mannan, O., Eyre, M., Löbel, U., Bamford, A., Eltze, C., Hameed, B., … & Hacohen, Y. (2020). Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA neurology, 77(11), 1440-1445.
  • Bilder, R. M., Postal, K. S., Barisa, M., Aase, D. M., Cullum, C. M., Gillaspy, S. R., … & Woodhouse, J. (2020). InterOrganizational practice committee recommendations/guidance for teleneuropsychology (TeleNP) in response to the COVID-19 pandemic. The Clinical Neuropsychologist, 34(7-8), 1314-1334.
  • Bilotta, F., Giordano, G., Sergi, P. G., & Pugliese, F. (2019). Harmful effects of mechanical ventilation on neurocognitive functions.
  • Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020). The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet.
  • Condie, L. O. (2020). Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children. Child Neuropsychology, 1-20.
  • Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., … & Galli, M. (2020). Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clinical Infectious Diseases.
  • Hampshire, A., Trender, W., Chamberlain, S., Jolly, A., Grant, J. E., Patrick, F., … & Mehta, M. A. (2020). Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N= 84,285 online study. MedRxiv.
  • Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., … & Meziani, F. (2020). Neurologic features in severe SARS-CoV-2 infection. New England Journal of Medicine.
  • Hewitt, K. C., Rodgin, S., Loring, D. W., Pritchard, A. E., & Jacobson, L. A. (2020). Transitioning to telehealth neuropsychology service: Considerations across adult and pediatric care settings. The Clinical Neuropsychologist, 34(7-8), 1335-1351.
  • Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., … & Cao, B. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet.
  • Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
  • Islam, M. R., Rahman, T., Ahmed, S. M., Khan, M. S. H., Azad, M. R., Alam, D., & Habib, R. (2020). Neurological presentation of COVID-19: experience from a tertiary care hospital of Bangladesh. BIRDEM Medical Journal, 33-40.
  • Josephson, S. A., & Kamel, H. (2020). Neurology and COVID-19. Jama, 324(12), 1139-1140.
  • Kaseda, E. T., & Levine, A. J. (2020). Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. The Clinical Neuropsychologist, 34(7-8), 1498-1514.
  • Kennedy, M., Helfand, B. K., Gou, R. Y., Gartaganis, S. L., Webb, M., Moccia, J. M., … & Inouye, S. K. (2020). Delirium in Older Patients With COVID-19 Presenting to the Emergency Department. JAMA network open, 3(11), e2029540-e2029540.
  • Kotfis, K., Williams Roberson, S., Wilson, J. E., Dabrowski, W., Pun, B. T., & Ely, E. W. (2020). COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Critical care, 24, 1-9.
  • Lee, M. H., Perl, D. P., Nair, G., Li, W., Maric, D., Murray, H., … & Nath, A. (2020). Microvascular Injury in the Brains of Patients with Covid-19. New England Journal of Medicine.
  • Li, Y. C., Bai, W. Z., & Hashikawa, T. (2020). The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. Journal of medical virology, 92(6), 552-555.
  • Lindan, C. E., Mankad, K., Ram, D., Kociolek, L. K., Silvera, V. M., Boddaert, N., … & Vézina, G. (2020). Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. The Lancet Child & Adolescent Health.
  • Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., … & Hu, B. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology, 77(6), 683-690.
  • Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS, Kahan J, Lansdale KN, LeMoss NM, Murthy SB, Stieg PE, Fink ME, Iadecola C, Segal AZ, Cusick M, Campion TR Jr, Diaz I, Zhang C, Navi BB. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurol. 2020 Jul 2;77(11):1–7. doi: 10.1001/jamaneurol.2020.2730. Epub ahead of print. PMID: 32614385; PMCID: PMC7333175.
  • Miners, S., Kehoe, P. G., & Love, S. (2020). Cognitive impact of COVID-19: looking beyond the short term. Alzheimer’s research & therapy, 12(1), 1-16.
  • Moro E, Priori A, Beghi E, Helbok R, Campiglio L, Bassetti CL, Bianchi E, Maia LF, Ozturk S, Cavallieri F, Zedde M, Sellner J, Bereczki D, Rakusa M, Di Liberto G, Sauerbier A, Pisani A, Macerollo A, Soffietti R, Taba P, Crean M, Twardzik A, Oreja-Guevara C, Bodini B, Jenkins TM, von Oertzen TJ; EAN core COVID-19 Task Force. The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection. Eur J Neurol. 2020 Sep;27(9):1727-1737. doi: 10.1111/ene.14407. Epub 2020 Jul 23. PMID: 32558002; PMCID: PMC7323212.
  • Natoli, S., Oliveira, V., Calabresi, P., Maia, L. F., & Pisani, A. (2020). Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models. European journal of neurology.
  • Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., … & Zandi, M. S. (2020). The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain, 143(10), 3104-3120.
  • Parlar, M. E., Spilka, M. J., Wong Gonzalez, D., Ballantyne, E. C., Dool, C., Gojmerac, C., … & MacKillop, E. (2020). “You can’t touch this”: Delivery of inpatient neuropsychological assessment in the era of COVID-19 and beyond. The Clinical Neuropsychologist, 34(7-8), 1395-1410.
  • Pleasure, S. J., Green, A. J., & Josephson, S. A. (2020). The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines. JAMA neurology, 77(6), 679-680.
  • Politi, L. S., Salsano, E., & Grimaldi, M. (2020). Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (covid-19) and anosmia. JAMA Neurology.
  • Rabinovitz, B., Jaywant, A., & Fridman, C. B. (2020). Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: implications for the current COVID-19 pandemic. The Clinical Neuropsychologist, 34(7-8), 1453-1479.
  • Rhea, E. M., Logsdon, A. F., Hansen, K. M., Williams, L. M., Reed, M. J., Baumann, K. K., … & Erickson, M. A. (2020). The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nature Neuroscience, 1-11.
  • Riordan, P., Stika, M., Goldberg, J., & Drzewiecki, M. (2020). COVID-19 and clinical neuropsychology: A review of neuropsychological literature on acute and chronic pulmonary disease. The Clinical Neuropsychologist, 34(7-8), 1480-1497.
  • Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., … & David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry.
  • Sultana, S., & Ananthapur, V. (2020). COVID-19 and its impact on neurological manifestations and mental health: the present scenario. Neurological Sciences, 1-6.
  • Sinha, P., Matthay, M. A., & Calfee, C. S. (2020). Is a “cytokine storm” relevant to COVID-19?. JAMA internal medicine, 180(9), 1152-1154.
  • Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2020). Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry.
  • Tong, J. Y., Wong, A., Zhu, D., Fastenberg, J. H., & Tham, T. (2020). The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngology–Head and Neck Surgery, 0194599820926473.
  • Virhammar, J., Nääs, A., Fällmar, D., Cunningham, J. L., Klang, A., Ashton, N. J., … & Rostami, E. (2020). Biomarkers for CNS injury in CSF are elevated in COVID‐19 and associated with neurological symptoms and disease severity. European journal of neurology.
  • Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., … & Yang, C. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, behavior, and immunity.
  • Zhou, H., Lu, S., Chen, J., Wei, N., Wang, D., Lyu, H., … & Hu, S. (2020). The landscape of cognitive function in recovered COVID-19 patients. Journal of Psychiatric Research, 129, 98-102.
  • Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020). Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurology.